Alfasigma Acquires the European Llicense for Bentracimab from ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
BOLOGNA, Italy, June 22, 2021 /PRNewswire-AsiaNet/-- -- The agreement covers the countries of the European Union, the EuropeanEconomic Area, the United Kingdom, Ukraine, Russia and the CIS-- Bentracimab is a human monoclonal antibody fragment to counteract the antiplatelet effects of...
Authors: LATEST ASIANET NEWS RELEASES